NAMS - NewAmsterdam Pharma Co N.V.

31.18
0.775   2.486%

Share volume: 883,667
Last Updated: 03-04-2026
Pharmaceutical Products/Pharmaceutical Preparations: 3.72%

PREVIOUS CLOSE
CHG
CHG%
$30.40
0.00
0.00%
5D - 1M - 3M - 1Y - 3Y - 5Y - 10Y - 15Y
Overview Charts Financials Fundamental analysis Historical prices Events Documents Notes Dividends
Fundamental analysis
41%
Profitability 35%
Dept financing 20%
Liquidity 50%
Performance 50%
Company vs Stock growth
vs
+ Add row to compare
Performance
5 Days
-14.26%
1 Month
-7.81%
3 Months
-15.19%
6 Months
18.49%
1 Year
41.42%
2 Year
31.91%
Key data
Stock price
$31.18
P/E Ratio 
0.00
DAY RANGE
$30.12 - $31.59
EPS 
-$2.48
52 WEEK RANGE
$14.06 - $42.00
52 WEEK CHANGE
$32.08
MARKET CAP 
3.978 B
YIELD 
N/A
SHARES OUTSTANDING 
114.975 M
DIVIDEND
N/A
EX-DIVIDEND DATE
N/A
NEXT EARNINGS DATE
08-06-2025
BETA 
0.77
PUBLIC FLOAT 
$0
AVERAGE 10 VOLUME 
$1,015,400
AVERAGE 30 VOLUME 
$804,310
Company detail
CEO: Michael H. Davidson
Region: US
Website: newamsterdampharma.com
Employees: 4
IPO year: 2022
Issue type: Common Stock
Market: XNAS
Industry: Pharmaceutical Products/Pharmaceutical Preparations
Sector: Manufacturing

Recent news